32.80
0.08 (0.24%)
| 前收盘价格 | 32.72 |
| 收盘价格 | 32.72 |
| 成交量 | 200,154 |
| 平均成交量 (3个月) | 584,589 |
| 市值 | 19,301,584,896 |
| 市盈率 (P/E TTM) | 156.19 |
| 预期市盈率 (P/E Forward) | 48.78 |
| 价格/销量 (P/S) | 11.28 |
| 股市价格/股市净资产 (P/B) | 10.81 |
| 52周波幅 | |
| 利润日期 | 28 May 2025 |
| 股息率 (DY TTM) | 1.17% |
| 营业毛利率 | 9.44% |
| 营业利益率 (TTM) | 22.93% |
| 稀释每股收益 (EPS TTM) | 0.210 |
| 季度收入增长率 (YOY) | 18.40% |
| 季度盈利增长率 (YOY) | 42.80% |
| 总债务/股东权益 (D/E MRQ) | 7.82% |
| 流动比率 (MRQ) | 2.06 |
| 营业现金流 (OCF TTM) | 506.10 M |
| 杠杆自由现金流 (LFCF TTM) | 303.21 M |
| 资产报酬率 (ROA TTM) | 10.85% |
| 股东权益报酬率 (ROE TTM) | 9.70% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Medical Instruments & Supplies (AU) | 混合的 | 混合的 |
| Medical Instruments & Supplies (全球的) | 看跌 | 混合的 | |
| 股票 | F&P HEALTH FPO NZX [FPH] | - | - |
AIStockmoo 评分
| 分析师共识 | 0.0 |
| 内部交易活动 | NA |
| 价格波动 | 1.0 |
| 技术平均移动指标 | 5.0 |
| 技术振荡指标 | 4.0 |
| 平均 | 2.50 |
|
Fisher & Paykel Healthcare is one of the three largest respiratory care device companies globally. It is the market leader in hospital use humidifiers, masks and related consumables and the number three player in the at-home treatment of sleep apnea using respiratory devices. Both the hospital and homecare markets for respiratory devices are growing strongly in the developed markets in which Fisher & Paykel has a presence. The company earns 42% of its revenue in the US, 32% in Europe, 18% in Asia-Pacific and the remaining 8% in emerging markets. Fisher conducts its own R&D and has thousands of patents and pending applications. It manufactures in New Zealand and Mexico and has a multichannel distribution model. |
|
| 部门 | Healthcare |
| 行业 | Medical Instruments & Supplies |
| 投资方式 | Large Growth |
| 内部持股比例 | 6.95% |
| 机构持股比例 | 35.65% |
该时间范围内无数据。
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合